Olecranon bursitis caused by in a patient treated with CAR-T cells.

Med Mycol Case Rep

Department of Medical Microbiology and Infection Control, Amsterdam University Medical Centers, Amsterdam, the Netherlands.

Published: December 2022

Chimeric antigen receptor (CAR-) T cell therapy is a relatively new form of immunotherapy for hematological malignancies. Although patients are at increased risk of infection following CAR-T cell therapy, reports of fungal infections are scarce. We report a case of infection causing bursitis of the elbow in a lymphoma patient after treatment with CAR-T cells. The fungal bursitis relapsed under posaconazole treatment, but was cured after surgical extirpation of the bursa.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9637851PMC
http://dx.doi.org/10.1016/j.mmcr.2022.10.002DOI Listing

Publication Analysis

Top Keywords

car-t cells
8
cell therapy
8
olecranon bursitis
4
bursitis caused
4
caused patient
4
patient treated
4
treated car-t
4
cells chimeric
4
chimeric antigen
4
antigen receptor
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!